LOXL2 is a potent regulator of integrin α5 and integrin β1 protein levels in clinical clear cell renal cell carcinoma specimens, and the expression levels of LOXL2 and integrin α5 correlated with the pathologic tumor grades24. Here, LOXL2 is linked to clear cell renal carcinoma.